Summit Therapeutics Income Statement (2014-2026) | SMMT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Operating items
Research & Development (Quarter)	0.02B	0.02B	0.02B	0.02B	0.01B	0.02B	0.01B	0.01B	0.01B	0.02B	0.02B	0.03B	0.03B	0.04B	0.05B	0.05B	0.21B	0.13B	0.15B	0.13B
Share-based Compensation (IS) (Quarter)
Selling, General & Administrative (Quarter)	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.02B	0.01B	0.02B	0.36B	0.10B	0.08B	0.06B
Other Operating Expenses (Quarter)					0.00B	0.01B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B
Operating Expenses (Quarter)	0.03B	0.03B	0.03B	0.03B	0.02B	0.02B	0.02B	0.54B	0.02B	0.02B	0.04B	0.04B	0.06B	0.06B	0.07B	0.07B	0.57B	0.23B	0.22B	0.20B
Operating Income (Quarter)	-0.02B	-0.02B	-0.03B	-0.02B	-0.01B	-0.02B	-0.02B	-0.54B	-0.02B	-0.02B	-0.04B	-0.04B	-0.06B	-0.06B	-0.07B
EBIT (Quarter)	-0.02B	-0.02B	-0.03B	-0.02B	-0.01B	-0.02B	-0.02B	-0.54B	-0.02B	-0.02B	-0.04B	-0.04B	-0.06B	-0.06B	-0.07B
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)	-0.00B	-0.00B	-0.00B	0.00B	-0.00B	-0.00B	0.01B	-0.01B	0.00B	-0.00B	0.02B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B
Net income details
EBT (Quarter)	-0.02B	-0.02B	-0.03B	-0.02B	-0.01B	-0.02B	-0.02B	-0.54B	-0.02B	-0.02B	-0.04B	-0.05B	-0.06B	-0.06B	-0.07B
Tax Provisions (Quarter)
Profit After Tax (Quarter)	-0.02B	-0.02B	-0.03B	-0.02B	-0.02B	-0.02B	-0.02B	-0.54B	-0.01B	-0.02B	-0.04B	-0.04B	-0.06B	-0.06B	-0.06B	-0.06B	-0.57B	-0.23B	-0.22B	-0.19B
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)	-0.02B	-0.02B	-0.03B	-0.02B	-0.01B	-0.02B	-0.02B	-0.54B	-0.02B	-0.02B	-0.04B	-0.05B	-0.06B	-0.06B	-0.07B
Consolidated Net Income (Quarter)	-0.02B	-0.02B	-0.03B	-0.02B	-0.01B	-0.02B	-0.02B	-0.54B	-0.02B	-0.02B	-0.04B	-0.05B	-0.06B	-0.06B	-0.07B
Income towards Parent Company (Quarter)	-0.02B	-0.02B	-0.03B	-0.02B	-0.01B	-0.02B	-0.02B	-0.54B	-0.02B	-0.02B	-0.04B	-0.05B	-0.06B	-0.06B	-0.07B
Net Income towards Common Stockholders (Quarter)	-0.02B	-0.02B	-0.03B	-0.02B	-0.01B	-0.02B	-0.02B	-0.54B	-0.02B	-0.02B	-0.04B	-0.05B	-0.06B	-0.06B	-0.07B
Additional items
EPS (Basic) (Quarter)	-0.27	-0.20	-0.21	-0.15	-0.12	-0.10	-0.04	-1.43	-0.02	-0.03	-0.01	-0.06	-0.09	-0.08	-0.09	-0.09	-0.76	-0.31	-0.28	-0.24
EPS (Weighted Average and Diluted) (Quarter)	-0.27	-0.20	-0.21	-0.15	-0.12	-0.10	-0.04	-1.43	-0.02	-0.03	-0.01	-0.06	-0.09	-0.08	-0.09	-0.09	-0.76	-0.31	-0.28	-0.24
Shares Outstanding (Weighted Average) (Quarter)	0.09B	0.10B	0.13B	0.14B	0.14B	0.21B	0.19B	0.38B	0.70B	0.70B	0.62B	0.70B	0.70B	0.71B	0.72B	0.74B	0.74B	0.74B		0.78B
Shares Outstanding (Diluted Average) (Quarter)	0.09B	0.10B	0.13B	0.14B	0.14B	0.21B	0.19B	0.38B	0.54B	0.70B	0.62B	0.70B	0.70B	0.71B	0.72B	0.74B	0.74B	0.74B	0.75B	0.78B
EBITDA (Quarter)	-0.02B	-0.02B	-0.03B	-0.02B	-0.02B	-0.02B	-0.02B	-0.54B	-0.02B	-0.02B	-0.04B	-0.04B	-0.06B	-0.06B	-0.06B	-0.06B	-0.57B	-0.23B	-0.22B	-0.19B
Interest Expenses (Quarter)												0.00B	0.00B	0.00B	0.00B
Tax Rate (Quarter)

Research Tools

Developers

Summit Therapeutics Income Statement (2014-2026) | SMMT

Research Tools

Developers

Summit Therapeutics Income Statement (2014-2026) | SMMT

Create an account

Sign In

Reset Password